EFEPOETIN ALFA
UNII R6OS9S8VQ7

Substance Identification & Data

This profile provides standardized clinical and technical data for Efepoetin Alfa, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R6OS9S8VQ7.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1905452-78-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
R6OS9S8VQ7
CAS Registry Number
1905452-78-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EFEPOETIN ALFA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10605
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Efepoetin Alfa. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EFEPOETIN ALFA

Common Names & Synonyms

EFEPOETIN ALFA [INN]
EFEPOETIN ALFA [WHO-DD]
ERYTHROPOIETIN (HUMAN) FUSION PROTEIN WITH IMMUNOGLOBULIN (SYNTHETIC HYBRID FC FRAGMENT HYFC)
HUMAN ERYTHROPOIETIN (EPOETIN ALFA) FUSED TO A HYBRID HUMAN IMMUNOGLOBULIN (IG), CONSISTING OF THE FC FRAGMENT OF THE IGG4 FUSED TO THE HINGE AND AMINO-TERMINUS OF THE IGD HEAVY CHAIN ISOTYPE 2, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA